Targeting inflammation to treat diabetic kidney disease: the road to 2030
SRSandra Rayego‐MateosRRRaúl R. Rodrigues-DíezBFBeatriz Fernández‐FernándezCMCarmen Mora‐FernándezVMVanessa Marchant
Hospital Universitario Fundación Jiménez Díaz · Instituto de Salud Carlos III · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
339
total citations
- FWCI
- 43.40
- Percentile
- 100%
- References
- 190
Citations per year
Authors
9- SRSandra Rayego‐MateosCorresponding
Hospital Universitario Fundación Jiménez Díaz, Instituto de Salud Carlos III
- RRRaúl R. Rodrigues-Díez
Instituto de Investigación Sanitaria del Principado de Asturias, Instituto de Salud Carlos III
- BFBeatriz Fernández‐Fernández
Instituto de Salud Carlos III, Hospital Universitario Fundación Jiménez Díaz
- CMCarmen Mora‐Fernández
Instituto de Salud Carlos III, Hospital Universitario Nuestra Señora de Candelaria
- VMVanessa Marchant
Hospital Universitario Fundación Jiménez Díaz, Instituto de Salud Carlos III
Topics & keywords
Topics
Keywords
- Medicine
- Inflammation
- Clinical trial
- Kidney disease
- Disease
- Pathogenesis
- Intensive care medicine
- Mineralocorticoid receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.